AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

ICONIC LABS PLC

Delisting Announcement Feb 13, 2025

4953_rns_2025-02-13_4dd803f0-3067-4e7a-8c5c-87ca98a45f11.html

Delisting Announcement

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 0860X

Iconic Labs PLC

13 February 2025

Iconic Labs PLC

("Iconic" or the "Company")

Transaction Terminated

On 11 March 2024 the Company entered into a non-binding heads of terms with the owners of ITS Holdings 2023 Ltd (the "Target"), the holder of the entire issued share capital of In the Style Fashion Ltd, an online fashion retailer, in connection with the potential purchase of the entire issued share capital of the Target ("Transaction").

The Board wishes to announce that the Transaction, which would have constituted a reverse takeover under the UK Listing Rules, will not proceed to conclusion.

The Directors of Iconic are now assessing alternative transactions and will make an announcement in due course.

The Directors will now request that the Financial Conduct Authority the restoration of the Company's listing on the Official List and to trading on the Main Market of the London Stock Exchange.

This announcement contains information which, prior to its disclosure, was inside information as stipulated under Regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310 (as amended).   

- ENDS -

For more information, please contact:

Iconic Labs

John Farquharson, Interim Chief Executive Officer
via Yellow Jersey PR
Novum Securities Limited

David Coffman / Daniel Harris
Tel: +44 (0) 20 7399 9400
Yellow Jersey PR

Charles Goodwin

Annabelle Wills

Bessie Elliot
Tel: +44 (0) 20 3004 9512

[email protected]

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCKZGMZNFDGKZM

Talk to a Data Expert

Have a question? We'll get back to you promptly.